Genetic Epidemiology of Responses to Antihypertensives

Trial Profile

Genetic Epidemiology of Responses to Antihypertensives

Phase of Trial: Phase IV

Latest Information Update: 29 Jan 2013

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms GERA
  • Most Recent Events

    • 29 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top